Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The combination therapy significantly improved Riehl’s melanosis in patients without serious side effects.

PTH-CBD agonists may help regrow hair after chemotherapy.

Biobran MGN-3 reduces chemotherapy side effects and improves quality of life for breast cancer patients.

Targeting the PGD2-DP2 pathway may help treat hair loss.

Targeting androgen receptors with antiandrogen oligonucleotides could effectively treat hair loss.

New and future treatments for male hypogonadism include various forms of testosterone therapy and emerging drugs.

Injecting patients' own PRP into their thyroid improved thyroid function and symptoms in most hypothyroidism cases.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

Combining α-blockers with 5α-reductase inhibitors improves symptoms and outcomes for severe benign prostatic hyperplasia.

Breathing in newborn rats is affected differently by hormones based on their sex.

Anagen grow may effectively treat hair loss by blocking testosterone and reducing enzyme activity.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Using minoxidil and anthralin together can improve hair regrowth in severe alopecia areata patients who didn't respond to individual treatments.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

GLP-1 receptor agonists may cause hair loss, but more research is needed.

The patient likely has Chrousos syndrome, a rare condition causing insensitivity to glucocorticoids, requiring high-dose dexamethasone treatment.

Rizatriptan benzoate-loaded dissolving microneedles are effective and convenient for treating acute migraines.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Gender-affirming hormone therapy in South Korea aligns with international guidelines and has specific side effects.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

High-dose androgen therapy can help manage certain types of androgen resistance.

Early advanced therapies are crucial for better survival in aggressive insulinoma cases.

The combination of minoxidil, microneedling, and PRP is more effective for hair growth than minoxidil alone.

Hormonal contraceptives may reduce social behavior and sexual motivation by lowering allopregnanolone levels.

Double-stranded RNA helps regenerate hair follicles by increasing retinoic acid production and signaling.

Gene therapy and new treatments offer hope for HTRA1-related disorders.

Rash from EGFRI treatment can indicate both side effects and treatment effectiveness.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Microneedling may improve hair loss treatments by enhancing drug delivery and hair growth.